India’s Dr. Reddy’s To Focus On Providing Niche Services
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories of India plans to change the way it does business, focusing on niche services to gain an edge in the highly competitive generic drugs business. As a lead-up to the new emphasis, the company has combined its custom pharmaceutical services with its division for active pharmaceutical ingredients. The new division is called Pharmaceutical Services and Active Ingredients. A senior vice president at Dr. Reddy's, Abhijit Mukerjee, is to head the new division, and says the move is intended to take advantage of "a huge wealth of expertise." His division plans to provide research and manufacturing services matched to its clients, many of the services involving chemical molecules. (Click here for more